This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: An Martine M De Creus: Innovator in Hepatitis B Treatment
Introduction
An Martine M De Creus is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of medicine, particularly in the treatment of viral infections. His innovative work has led to the development of a patent that addresses a critical health issue.
Latest Patents
An Martine M De Creus holds a patent for "Toll-like receptor agonists for use in the treatment of hepatitis B." This patent includes formulations and methods for using a TLR-7 agonist to treat hepatitis B virus infection. His work in this area is crucial for advancing therapeutic options for patients suffering from this condition.
Career Highlights
De Creus is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to contribute to pharmaceutical innovations. His expertise in immunology and virology has positioned him as a key figure in the development of new treatments.
Collaborations
He has collaborated with notable colleagues such as Peter Jozef M Van Remoortere and Sean Mark Dalziel. These partnerships have enhanced the research and development efforts within his field.
Conclusion
An Martine M De Creus is a distinguished inventor whose work in hepatitis B treatment exemplifies the impact of innovative research in medicine. His contributions are vital for improving patient outcomes and advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile